Gideon Shapiro
Corporate Officer/Principal presso BRIGHT MINDS BIOSCIENCES INC.
Patrimonio netto: 362 032 $ in data 31/05/2024
Profilo
Gideon Shapiro is the founder of Somatocor Pharmaceuticals, Inc., EraGen Biosciences, Inc. He is currently the Vice President-Discovery at Bright Minds Biosciences, Inc. He was previously the Chief Science Officer at Rugen Therapeutics and Vice President-Chemistry at FORUM Pharmaceuticals, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 22/12/2023 | 299 200 ( 6.70% ) | 362 032 $ | 31/05/2024 |
Posizioni attive di Gideon Shapiro
| Società | Posizione | Inizio |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Corporate Officer/Principal | 29/09/2020 |
Precedenti posizioni note di Gideon Shapiro
| Società | Posizione | Fine |
|---|---|---|
| Rugen Therapeutics | Corporate Officer/Principal | 01/01/2019 |
| Somatocor Pharmaceuticals, Inc. | Fondatore | - |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Corporate Officer/Principal | - |
EraGen Biosciences, Inc.
 EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Aziende private | 4 |
|---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
EraGen Biosciences, Inc.
EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Health Technology |
| Somatocor Pharmaceuticals, Inc. | |
| Rugen Therapeutics |
- Borsa valori
- Insiders
- Gideon Shapiro
